Allergan’s assignment of the patents on one of its blockbuster drugs to an American Indian tribe in an attempt to dismiss a USPTO inter partes review (IPR) proceeding on “tribal sovereign immunity”…
In a dispute between patent holder B/E Aerospace and C&D Zodiac that was instituted by C&D’s petition for inter partes review of B/E’s patent for saving space in airplanes, the Patent trail…
Following inter partes review of several claims of a patent directed to a trigger/seal mechanism for a beverage container, the Patent Trial and Appeal Board properly applied the broadest reasonable…
The Patent Trial and Appeal Board’s construction of the term "body" disclosed in multiple claims of a downhole drilling tool patent has been reversed by the U.S. Court of Appeals for the Federal…
Substantial evidence supported a Patent Trial and Appeal Board decision finding a patent for an eyewear retention device unpatentable as obvious, the U.S. Court of Appeals for the Federal Circuit has…
The Patent Trial and Appeal Board’s construction of a key claim term in a patent directed to a method for fabricating a self-aligned contact hole in a semiconductor circuit was overbroad in light of…
Decisions by the Patent Trial and Appeal Board in three interference proceedings between Stanford University and the Chinese University of Hong Kong ("CUHK")—in which the Board found that methods of…
The Patent Trial and Appeal Board did not err in instituting Covered Business Method ("CBM") review and finding several claims of a financing method patent owned by Credit Acceptance Corporation ("…
The Patent Trial and Appeal Board erroneously construed the term "aseptic" in an inter partes review (IPR) of a patent for a method of aseptically bottling sterilized food, the U.S. Court of Appeals…
To the extent that the Patent Trial and Appeal Board did not provide an explanation for its obviousness rejection of 13 claims of a Securus patent on a system and method for reviewing monitored…
